Option chain shows key data for Serina Therapeutics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Serina Therapeutics.

Serina Therapeutics (AMEX:SER) Stock, Option Chain

Serina Therapeutics

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

Analyst,Woman,Working,With,Information,Database,To,Analyze,Marketing,And

News

Initiation

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

INUV

OCUL

PRIM

This Primoris Services Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Cassava Sciences, Zoom, Kohl's, Rivian, Tesla: Why These 5 Stocks Are On Investors' Radars Today

Movers

CRDO

CTNT

CTOR

FRME

GELS

JANX

KITT

OMEX

OPTT

SGBX

SHIM

SOAR

Why Credo Technology Group Shares Are Trading Higher By 40%; Here Are 20 Stocks Moving Premarket

Serina Therapeutics Inc

Sera Prognostics, Inc. - Class A Common Stock

Sera Prognostics Inc

Serko Ltd

Seiren Co Ltd

Super Zero Protocol

Serve Robotics Inc

Press Releases

Serina Therapeutics Welcomes Karen J. Wilson to its Board of Directors

Serina Therapeutics Announces Sale of UniverXome Subsidiary

Serina Therapeutics Receives Second $5 Million Tranche to Strengthen Cash Position Ahead of Phase 1 Clinical Trial in Advanced Parkinson's Disease Patients

Serina Therapeutics Appoints Dr. Jay Venkatesan to its Board of Directors

Serina Therapeutics to Present at the American Chemistry Society (ACS) Spring 2025 Meeting

Serina Therapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights

Serina Therapeutics to Present at the Jones Healthcare and Technology Innovation Conference

Serina Therapeutics Secures $5 Million in Funding to Support Advancement of SER-252 into Clinical Development in Advanced Parkinson's Disease

Serina Therapeutics to Present at the 4th LNP Formulation & Process Development Summit

Serina Therapeutics to Present at JonesResearch Virtual CNS Day

Adicet Bio

Applied Therapeutics, Inc. - Common Stock

Applied Therapeutics

Armata Pharmaceuticals, Inc. Common Stock

Armata Pharmaceuticals

Artiva Biotherapeutics, Inc. - Common Stock

Artiva Biotherapeutics

Avalo Therapeutics

Cabaletta Bio

Citius Oncology

Cue Biopharma

Precision BioSciences, Inc. - Common Stock

Precision BioSciences

Fortress Biotech

Gain Therapeutics

Immix Biopharma

Century Therapeutics, Inc. - Common Stock

Century Therapeutics

Karyopharm Therapeutics Inc. - Common Stock

Karyopharm Therapeutics

MAIA Biotechnology

Metagenomi

OKYO Pharma

Outlook Therapeutics, Inc. - Common Stock

Outlook Therapeutics

PDS Biotechnology Corporation - Common Stock

PDS Biotechnology

PMV Pharma

Quince Therapeutics

Renovaro

Repare Therapeutics

Skye Bioscience

vTv Therapeutics Inc. - Class A Common Stock

vTv Therapeutics

Jones Trading

Comments

Serina Therapeutics

Serina Therapeutics (SER) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell